Delivery Order SPE2DB20D2104-SPE2DB24FU36A
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Biktarvy 50-200-25 mg tablets in 30-count packages. The $10,172.22 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 25, 2024. Amerisourcebergen holds a Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract. The award, valued at $10,807.48, has an ultimate completion date of June 28, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA). The $39,482.98 Firm Fixed Price Delivery Order has an ultimate completion date of April 24, 2024 and was awarded on April 23, 2024. Amerisourcebergen holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,397.67 delivery order contract is for the supply of Biktarvy 50-200-25 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of May 25, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a delivery order valued at $20,950.16 for the supply of Biktarvy 50-200-25 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) and has a period of performance through September 30, 2024. Amerisourcebergen, as one of the largest pharmaceutical distributors in the United States, has been a significant supplier of medical commodities to various federal agencies, including the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is an order valued at $5,270.78 for the delivery of BIKTARVY 50-200-25 mg Tablets. The contract was awarded by the Defense Logistics Agency (DLA) and is a Firm Fixed Price Delivery Order with a completion date of July 17, 2024. This order is not designated as a set-aside. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. government, including military treatment...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $4,644.48 firm fixed-price delivery order is for 30 units of the drug BIKTARVY 50-200-25 MG TABLET. The contract has an ultimate completion date of May 20, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX,...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a $20,194.65 firm fixed-price delivery order contract for the pharmaceutical product BIKTARVY 50-200-25 MG TABLET UU 30S. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, to provide a wide range of pharmaceutical products and medical supplies to support the Department of Defense's global medical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $75,326.43 for the supply of BIKTARVY 50-200-25 MG TABLET. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 10, 2022. The contract is a Firm Fixed Price arrangement with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,439.87 Firm Fixed Price Delivery Order contract is for the supply of the pharmaceutical product BIKTARVY 50-200-25 MG TABLET UU 30S. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FU36ADelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Biktarvy 50-200-25 mg tablet in quantities of 30 per unit. The $5,036.04 Firm Fixed Price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 24, 2024. Amerisourcebergen, a major supplier of pharmaceuticals and medical supplies to the federal government, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of medical products and supplies to support the Department of Defense worldwide. This contract represents a significant portion of Amerisourcebergen's federal business. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 5/23/24 |